Has Rose Joyner received payments from drug or device companies?

Yes. Drug and device makers reported $4,421 in general payments to Rose Joyner across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rose Joyner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rose Joyner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rose Joyner

Nurse Practitioner · Midlothian, VANPI 1508239526

Payments from drug & device makers

$4,421in general payments, 2019–2025

Across 85 payments — averaging $52.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$680
Neurocrine Biosciences, Inc.$625
AbbVie$395
Lilly USA, LLC$298
SK Life Science, Inc.$238
E.r. Squibb & Sons, L.L.C.$194
plus $2K from 21 others

What the payments were for

Food & beverage$4,421100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	18	$680
Neurocrine Biosciences, Inc.	8	$625
AbbVie	10	$395
Lilly USA, LLC	6	$298
SK Life Science, Inc.	2	$238
E.r. Squibb & Sons, L.L.C.	2	$194
Otsuka America Pharmaceutical, Inc.	4	$171
Biogen	2	$161
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$154
AstraZeneca	2	$151
Biohaven Pharmaceutical Holding Company Ltd.	3	$134
Biohaven Pharmaceuticals, Inc.	1	$123
Supernus Pharmaceuticals, Inc.	2	$122
Axsome Therapeutics, Inc.	1	$121
Boston Scientific	1	$120
Antares Pharma, Inc.	1	$115
Paratek Pharmaceuticals, Inc.	1	$109
Lundbeck LLC	3	$105
Halozyme Inc	1	$103
Johnson & Johnson	1	$88
Currax Pharmaceuticals LLC	5	$71
Collegium Pharmaceutical, Inc.	2	$41
Teva Pharmaceuticals USA, Inc.	2	$34
Vanda Pharmaceuticals Inc.	1	$24
Neos Therapeutics, LP	1	$17
Bausch Health US, LLC	1	$15
TMS Neurohealth Centers Inc.	2	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,421 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia →

Other nurse practitioner in Midlothian

Julie JulianMidlothian$14K
Kelly McAuliffeMidlothian$9K
Samantha FoxGate City$207K
Mikel GrayCharlottesville$174K
Kevin BrigleRichmond$166K
Denese GomesRichmond$126K
Ashley CarmenAlexandria$99K
Rachel AndersonCharlottesville$90K
Megan FrancisArlington$81K
Elizabeth WilletteNorfolk$58K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →